SBI Healthcare Opportunities Fund - IDCW - Direct Plan

  • Previous Nav

  • Net Change on 18-12-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) -3.20 -2.84 -0.24 24.90 18.06 17.39
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jan 01, 2013 -0.24 24.90 18.06 0.91 4,130.76
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option Jan 01, 2013 0.91 22.48 16.46 0.91 8,458.68
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option Jul 13, 2018 4.30 28.26 18.84 1.02 6,459.82
DSP Healthcare Fund - Direct Plan - IDCW Nov 30, 2018 -4.54 22.42 17.03 0.56 3,178.53
Mirae Asset Healthcare Fund Direct IDCW Jul 02, 2018 1.72 22.75 17.09 0.47 2,812.12
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 0.02 23.57 16.92 0.61 1,338.85

Fund Holdings as on 30-November-2025

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Max Healthcare Institute Ltd.

  • Cipla Ltd.

  • TREPS

  • Lupin Ltd.

  • Lonza Group

  • Acutaas Chemicals Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Laurus Labs Ltd.

  • Fortis Healthcare Ltd.

  • Aster DM Healthcare Ltd.

  • Jupiter Life Line Hospitals Ltd.

  • Biocon Ltd.

  • Gland Pharma Ltd.

  • Aether Industries Ltd.

  • Mankind Pharma Ltd.

  • Abbott India Ltd.

  • Krishna Institute of Medical Sciences Ltd.

  • Polymedicure Ltd.

  • Alkem Laboratories Ltd.

  • Concord Biotech Ltd.

  • Aurobindo Pharma Ltd.

  • Anthem Biosciences Ltd.

  • Cohance Lifesciences Ltd.

  • Vijaya Diagnostic Centre Ltd.

  • Pfizer Ltd.

  • Medplus Health Services Ltd.

  • Gufic Biosciences Ltd.

  • Sanofi Consumer Healthcare India Ltd.

  • Sudeep Pharma Ltd.

  • Rainbow Children's Medicare Ltd.

  • 364 DAY T-BILL 19.11.26

  • Net Receivable / Payable

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Chemicals

  • Medical Equipment/Supplies/Accessories

  • Retailing

View More

Fund Manager

Most Recent Dividend

  • 16/03/2018

  • Cash

  • Equity

  • Sovereign

View More

About SBI Healthcare Opportunities Fund

Scheme Analysis

SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 01-Jan-2013 and currently has an AUM of ₹4,130.76 crore. SBI Healthcare Opportunities Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of SBI Healthcare Opportunities Fund ended down ₹-0.88(-0.26%)yesterday to ₹334.9637.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai .

Fund House Contact

9th Floor, Crescenzo, C - 38 & 39 G Block, BKC, Bandra (East) Mumbai - 400 051

022 - 61793537
022 - 22189663
www.sbimf.com